The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.

A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...

Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the ...

Even if you’re not experiencing any GI symptoms right now, certain habits can help ensure your gut stays in tip-top shape.